OptimizeRx Corporation (OPRX)

NASDAQ: OPRX · Real-Time Price · USD
18.07
-0.16 (-0.88%)
At close: Aug 29, 2025, 4:00 PM
18.53
+0.46 (2.55%)
After-hours: Aug 29, 2025, 7:10 PM EDT
-0.88%
Market Cap335.47M
Revenue (ttm)104.75M
Net Income (ttm)-9.87M
Shares Out 18.57M
EPS (ttm)-0.54
PE Ration/a
Forward PE34.49
Dividendn/a
Ex-Dividend Daten/a
Volume332,219
Open18.37
Previous Close18.23
Day's Range17.69 - 18.46
52-Week Range3.78 - 18.96
Beta1.33
AnalystsBuy
Price Target11.81 (-34.64%)
Earnings DateAug 7, 2025

About OPRX

OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and... [Read more]

Sector Healthcare
Founded 2006
Employees 129
Stock Exchange NASDAQ
Ticker Symbol OPRX
Full Company Profile

Financial Performance

In 2024, OptimizeRx's revenue was $92.13 million, an increase of 28.81% compared to the previous year's $71.52 million. Losses were -$20.11 million, 14.5% more than in 2023.

Financial Statements

Analyst Summary

According to 8 analysts, the average rating for OPRX stock is "Buy." The 12-month stock price target is $11.81, which is a decrease of -34.64% from the latest price.

Price Target
$11.81
(-34.64% downside)
Analyst Consensus: Buy
Stock Forecasts

News

OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth

WALTHAM, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

11 days ago - GlobeNewsWire

OptimizeRx Corporation (OPRX) Q2 2025 Earnings Call Transcript

OptimizeRx Corporation (NASDAQ:OPRX) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Andrew Jacob D'Silva - Senior Vice President of Corporate Finance Edward Stelmakh ...

22 days ago - Seeking Alpha

OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

WALTHAM, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

23 days ago - GlobeNewsWire

OptimizeRx: Stock Could Rise As Profitability Is Achieved

I expect OptimizeRx to turn profitable in 2025, driven by strong double-digit revenue growth and reduced operating expenses. The company's proprietary AI-powered omnichannel platform connects over 2 m...

6 weeks ago - Seeking Alpha

OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET

WALTHAM, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

6 weeks ago - GlobeNewsWire

OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors

WALTHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

2 months ago - GlobeNewsWire

Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions

CANNES, France--(BUSINESS WIRE)-- #TV--Simulmedia announced a strategic partnership with OptimizeRx Corp. to enable the self-serve availability of Micro-Neighborhood® Targeting (MNT).

2 months ago - Business Wire

OptimizeRx to Participate in Upcoming Investor Conferences

WALTHAM, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage...

3 months ago - GlobeNewsWire

OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript

OptimizeRx Corporation (NASDAQ:OPRX) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET Company Participants Steve Silvestro - Chief Executive Officer Edward Stelmakh - Chief Financial Officer ...

3 months ago - Seeking Alpha

OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

WALTHAM, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage...

3 months ago - GlobeNewsWire

OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report

WALTHAM, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage...

4 months ago - GlobeNewsWire

OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET

WALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and enga...

4 months ago - GlobeNewsWire

OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment

WALTHAM, Mass., April 18, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and enga...

4 months ago - GlobeNewsWire

OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million

OPTIMIZERx Corp. OPRX, a health care technology firm, reported on Wednesday fourth-quarter sales of $32.32 million, up 14% year-over-year, beating the consensus of $30.36 million.

6 months ago - Benzinga

OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript

OptimizeRx Corporation (NASDAQ:OPRX) Q4 2024 Results Conference Call March 12, 2025 8:30 AM ET Company Participants Steve Silvestro - President Edward Stelmakh - Chief Financial Officer and Chief Ope...

6 months ago - Seeking Alpha

OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results

WALTHAM, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and enga...

6 months ago - GlobeNewsWire

OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations

WALTHAM, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and enga...

6 months ago - GlobeNewsWire

OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer

Silvestro has a demonstrated record of accelerating revenue growth, expanding brand relevance, and building a market-leading team Silvestro has a demonstrated record of accelerating revenue growth, ex...

6 months ago - GlobeNewsWire

OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET

WALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

6 months ago - GlobeNewsWire

OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO

WALTHAM, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

8 months ago - GlobeNewsWire

OptimizeRx Corporation (OPRX) Q3 2024 Earnings Call Transcript

OptimizeRx Corporation (NASDAQ:OPRX) Q3 2024 Results Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants William Febbo - Chief Executive Officer Edward Stelmakh - Chief Financi...

10 months ago - Seeking Alpha

OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET

WALTHAM, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

10 months ago - GlobeNewsWire

OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value

WALTHAM, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and en...

1 year ago - GlobeNewsWire

OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences

The availability of Micro-Neighborhood ® Targeting on the Company's Dynamic Audience Activation Platform meets the demand of life sciences marketers by synchronizing consumer and physician marketing

1 year ago - GlobeNewsWire

OptimizeRx Corporation (OPRX) Q2 2024 Earnings Call Transcript

OptimizeRx Corporation (NASDAQ:OPRX) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants William Febbo - CEO Ed Stelmakh - CFO Steve Silvestro - President Marion Odense-Fo...

1 year ago - Seeking Alpha